| SBF2-AS1 and TreRNA: novel lncRNA players in triple-negative breast cancer pathogenesis. | SBF2-AS1 and TreRNA: novel lncRNA players in triple-negative breast cancer pathogenesis.
Kamaliyan Z, Dorraji K, Kakavand S, Azizi-Tabesh G, Mirfakhraie N, Omranipour R, Ahmadinejad N, Yassaee VR, Mirfakhraie R. | 06/28/2023 |
| Knockdown of LncRNA SBF2-AS1 Inhibited Gastric Cancer Tumorigenesis via the Wnt/LRP5 Signaling Pathway. | Knockdown of LncRNA SBF2-AS1 Inhibited Gastric Cancer Tumorigenesis via the Wnt/LRP5 Signaling Pathway.
Liu Z, Li Q, Wang Y, Ge Y. | 01/11/2023 |
| LncRNA SBF2-AS1: A Budding Star in Various Cancers. | LncRNA SBF2-AS1: A Budding Star in Various Cancers.
Tan F, Chen J, Wang B, Du Z, Mou J, Wu Y, Liu Y, Zhao F, Yuan C. | 08/27/2022 |
| Silencing of SBF2-AS1 inhibits cell growth and invasion by sponging microRNA-338-3p in serous ovarian carcinoma. | Silencing of SBF2-AS1 inhibits cell growth and invasion by sponging microRNA-338-3p in serous ovarian carcinoma.
Luan AA, Hou LL, Zhang FY. | 04/23/2022 |
| Downregulation of lncRNA SBF2-AS1 inhibits hepatocellular carcinoma proliferation and migration by regulating the miR-361-5p/TGF-beta1 signaling pathway. | Downregulation of lncRNA SBF2-AS1 inhibits hepatocellular carcinoma proliferation and migration by regulating the miR-361-5p/TGF-β1 signaling pathway.
Wu YH, Yu B, Chen WX, Ai X, Zhang W, Dong W, Shao YJ., Free PMC Article | 01/15/2022 |
| Low expression of lncRNA SBF2-AS1 regulates the miR-302b-3p/TGFBR2 axis, promoting metastasis in laryngeal cancer. | Low expression of lncRNA SBF2-AS1 regulates the miR-302b-3p/TGFBR2 axis, promoting metastasis in laryngeal cancer.
Li Y, Tang B, Lyu K, Yue H, Wei F, Xu Y, Chen S, Lin Y, Cai Z, Guo X, Li C, Lei W. | 12/25/2021 |
| The Clinical Prognostic Value of lncRNA SBF2-AS1 in Cancer Patients: A Meta-Analysis. | The Clinical Prognostic Value of lncRNA SBF2-AS1 in Cancer Patients: A Meta-Analysis.
Wang J, Zhong P, Hua H., Free PMC Article | 12/4/2021 |
| Down-regulated lncRNA SBF2-AS1 in M2 macrophage-derived exosomes elevates miR-122-5p to restrict XIAP, thereby limiting pancreatic cancer development. | Down-regulated lncRNA SBF2-AS1 in M2 macrophage-derived exosomes elevates miR-122-5p to restrict XIAP, thereby limiting pancreatic cancer development.
Yin Z, Zhou Y, Ma T, Chen S, Shi N, Zou Y, Hou B, Zhang C., Free PMC Article | 10/2/2021 |
| The molecular mechanisms of the long noncoding RNA SBF2-AS1 in regulating the proliferation of oesophageal squamous cell carcinoma. | The molecular mechanisms of the long noncoding RNA SBF2-AS1 in regulating the proliferation of oesophageal squamous cell carcinoma.
Zha W, Li X, Tie X, Xing Y, Li H, Gao F, Ye T, Du W, Chen R, Liu Y., Free PMC Article | 08/28/2021 |
| Long Noncoding RNASBF2-AS1 Promotes Gastric Cancer Progression via Regulating miR-545/EMS1 Axis. | Long Noncoding RNASBF2-AS1 Promotes Gastric Cancer Progression via Regulating miR-545/EMS1 Axis.
He M, Feng L, Qi L, Rao M, Zhu Y., Free PMC Article | 04/3/2021 |
| LncRNA SBF2-AS1 affects the radiosensitivity of non-small cell lung cancer via modulating microRNA-302a/MBNL3 axis. | LncRNA SBF2-AS1 affects the radiosensitivity of non-small cell lung cancer via modulating microRNA-302a/MBNL3 axis.
Yu Z, Wang G, Zhang C, Liu Y, Chen W, Wang H, Liu H., Free PMC Article | 11/28/2020 |
| SBF2-AS1: An oncogenic lncRNA in small-cell lung cancer. | SBF2-AS1: An oncogenic lncRNA in small-cell lung cancer.
Zhang Y, Li Y, Han L, Zhang P, Sun S. | 09/5/2020 |
| E2F1-induced overexpression of SBF2-AS1 promotes the expression of GRB2 by targeting miR-362-3p to facilitate the metastasis of NSCLC | E2F1-Induced Overexpression of Long Noncoding RNA SBF2-AS1 Promotes Non-Small-Cell Lung Cancer Metastasis Through Regulating miR-362-3p/GRB2 Axis.
Wang A, Wang J. | 07/25/2020 |
| downregulation of miR-619-5p or HDAC3 overexpression reversed SBF2-AS1-silencing-caused suppression on proliferation and metastasis. | Long noncoding RNA SBF2-AS1 promotes colorectal cancer proliferation and invasion by inhibiting miR-619-5p activity and facilitating HDAC3 expression.
Chen G, Gu Y, Han P, Li Z, Zhao JL, Gao MZ. | 05/30/2020 |
| LncRNA SBF2-AS1 promotes hepatocellular carcinoma metastasis by regulating epithelial mesenchymal transformation. | LncRNA SBF2-AS1 promotes hepatocellular carcinoma metastasis by regulating EMT and predicts unfavorable prognosis.
Zhang YT, Li BP, Zhang B, Ma P, Wu QL, Ming L, Xie LM. | 12/7/2019 |
| SBF2-AS1 could act as a miRNA sponge in AML progression | Long noncoding RNA SBF2-AS1 act as a ceRNA to modulate cell proliferation via binding with miR-188-5p in acute myeloid leukemia.
Tian YJ, Wang YH, Xiao AJ, Li PL, Guo J, Wang TJ, Zhao DJ. | 08/31/2019 |
| Transcription factor ZEB1 was found to directly bind to the SBF2-AS1 promoter region to regulate SBF2-AS1 level and affected TMZ resistance in GBM cells. SBF2-AS1 functions as a ceRNA for miR-151a-3p, leading to the disinhibition of its endogenous target, X-ray repair cross complementing 4 (XRCC4), which enhances DSB repair in GBM cells. | Exosomal transfer of long non-coding RNA SBF2-AS1 enhances chemoresistance to temozolomide in glioblastoma.
Zhang Z, Yin J, Lu C, Wei Y, Zeng A, You Y., Free PMC Article | 08/17/2019 |
| LncRNA SBF2-AS1 expression is increased in cervical cancer (CC). High SBF2-AS1 expression was associated with advanced FIGO stage and lymph node metastasis of CC patients. Function assays shows that SBF2-AS1 inhibition significantly reduces CC cells proliferation both in vitro and in vivo. SBF2-AS1 upregulation restrain the activity of miR-361-5p and leads to overexpression of Forkhead Box Protein M1 in CC cells. | LncRNA SBF2-AS1 promotes the progression of cervical cancer by regulating miR-361-5p/FOXM1 axis.
Gao F, Feng J, Yao H, Li Y, Xi J, Yang J. | 08/3/2019 |
| Long non-coding RNA SBF2-AS1 modulated TGFBR1 through sponging miR-140-5p in hepatocellular carcinoma development and progression. | Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
Li Y, Liu G, Li X, Dong H, Xiao W, Lu S. | 01/12/2019 |
| Study identified a novel lncRNA SBF2-AS1 in non-small cell lung cancer (NSCLC) that is upregulated and correlated with advanced TNM stage. SBF2-AS1 could promote proliferation of NSCLC cells in vitro and in vivo, suggesting that it might be an oncogenic lncRNA in NSCLC. | High expression of long non-coding RNA SBF2-AS1 promotes proliferation in non-small cell lung cancer.
Lv J, Qiu M, Xia W, Liu C, Xu Y, Wang J, Leng X, Huang S, Zhu R, Zhao M, Ji F, Xu L, Xu K, Yin R., Free PMC Article | 12/17/2016 |